https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Autoinjectors Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

Published : Jul 2023

Report ID: ARC2440

Pages : 250

Format : Autoinjectors Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Autoinjectors Market

1.1. Definition and Scope

1.1.1. Definition of Autoinjectors

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Autoinjectors Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Autoinjectors Market By Therapy

1.2.3. Autoinjectors Market By Usage Type

1.2.4. Autoinjectors Market By Route of Administration

1.2.5. Autoinjectors Market By End-User

1.2.6. Autoinjectors Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Autoinjectors Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Autoinjectors Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Autoinjectors Market By Therapy

5.1. Introduction

5.2. Autoinjectors Revenue By Therapy

5.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Therapy, 2020-2032

5.2.2. Rheumatoid Arthritis

5.2.2.1. Rheumatoid Arthritis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Multiple Sclerosis

5.2.3.1. Multiple Sclerosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Diabetes

5.2.4.1. Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Anaphylaxis

5.2.5.1. Anaphylaxis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Other Therapies

5.2.6.1. Other Therapies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Autoinjectors Market By Usage Type

6.1. Introduction

6.2. Autoinjectors Revenue By Usage Type

6.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Usage Type, 2020-2032

6.2.2. Disposable Autoinjectors

6.2.2.1. Disposable Autoinjectors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Reusable Autoinjectors

6.2.3.1. Reusable Autoinjectors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Autoinjectors Market By Route of Administration

7.1. Introduction

7.2. Autoinjectors Revenue By Route of Administration

7.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Route of Administration, 2020-2032

7.2.2. Subcutaneous

7.2.2.1. Subcutaneous Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Intramuscular

7.2.3.1. Intramuscular Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Autoinjectors Market By End-User

8.1. Introduction

8.2. Autoinjectors Revenue By End-User

8.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By End-User, 2020-2032

8.2.2. Home Care Settings

8.2.2.1. Home Care Settings Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Hospitals & Clinics

8.2.3.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Ambulatory Surgical Centers

8.2.4.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Autoinjectors Market By Country 

9.1. North America Autoinjectors Market Overview

9.2. U.S.

9.2.1. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

9.2.2. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

9.2.3. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

9.2.4. U.S. Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

9.3. Canada

9.3.1. Canada Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

9.3.2. Canada Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

9.3.3. Canada Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

9.3.4. Canada Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Autoinjectors Market By Country

10.1. Europe Autoinjectors Market Overview

10.2. U.K.

10.2.1. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.2.2. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

10.2.3. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

10.2.4. U.K. Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

10.3. Germany

10.3.1. Germany Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.3.2. Germany Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

10.3.3. Germany Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

10.3.4. Germany Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

10.4. France

10.4.1. France Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.4.2. France Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

10.4.3. France Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

10.4.4. France Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

10.5. Spain

10.5.1. Spain Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.5.2. Spain Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

10.5.3. Spain Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

10.5.4. Spain Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

10.6.2. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

10.6.3. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

10.6.4. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Autoinjectors Market By Country

11.1. Asia Pacific Autoinjectors Market Overview

11.2. China

11.2.1. China Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.2.2. China Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

11.2.3. China Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

11.2.4. China Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.3. Japan

11.3.1. Japan Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.3.2. Japan Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

11.3.3. Japan Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

11.3.4. Japan Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.4. India

11.4.1. India Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.4.2. India Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

11.4.3. India Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

11.4.4. India Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.5. Australia

11.5.1. Australia Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.5.2. Australia Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

11.5.3. Australia Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

11.5.4. Australia Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.6. South Korea

11.6.1. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.6.2. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

11.6.3. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

11.6.4. South Korea Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

11.7.2. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

11.7.3. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

11.7.4. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Autoinjectors Market By Country

12.1. Latin America Autoinjectors Market Overview

12.2. Brazil

12.2.1. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

12.2.2. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

12.2.3. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

12.2.4. Brazil Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.3. Mexico

12.3.1. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

12.3.2. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

12.3.3. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

12.3.4. Mexico Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

12.4.2. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

12.4.3. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

12.4.4. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Autoinjectors Market By Country 

13.1. Middle East & Africa Autoinjectors Market Overview

13.2. GCC

13.2.1. GCC Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

13.2.2. GCC Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

13.2.3. GCC Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

13.2.4. GCC Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.3. South Africa

13.3.1. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

13.3.2. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

13.3.3. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

13.3.4. South Africa Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032

13.4.2. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032

13.4.3. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032

13.4.4. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Autoinjectors Market

14.1. Autoinjectors Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Autoinjectors Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. AbbVie, Inc.

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. AbbVie, Inc. 2022 Autoinjectors Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Amgen

15.3. Biogen Idec

15.4. Eli Lilly

15.5. Johnson & Johnson

15.6. Mylan N.V.

15.7. Owen Mumford

15.8. Pfizer, Inc.

15.9. Sanofi

15.10. Scandinavian Health Ltd.

15.11. Teva Pharmaceutical

15.12. Ypsomed

Frequently Asked Questions

What was the market size of the global autoinjectors in 2022?

The market size of autoinjectors was USD 51.3 Billion in 2022.

What is the CAGR of the global autoinjectors market from 2023 to 2032?

The CAGR of autoinjectors is 17.4% during the analysis period of 2023 to 2032.

Which are the key players in the autoinjectors market?

The key players operating in the global market are including AbbVie, Inc., Amgen, Biogen Idec, Eli Lilly, Johnson & Johnson, Mylan N.V., Owen Mumford, Pfizer, Inc., Sanofi, Scandinavian Health Ltd., Teva Pharmaceutical, Ypsomed, and others.

Which region dominated the global autoinjectors market share?

North America held the dominating position in autoinjectors industry during the analysis period of 2023 to 2032.

Which region registered fastest CAGR from 2023 to 2032?

Asia-Pacific region exhibited fastest growing CAGR for market of autoinjectors during the analysis period of 2023 to 2032.

What are the current trends and dynamics in the global autoinjectors industry?

The current trends and dynamics in the autoinjectors industry include benefits of autoinjectors in emergency medical care, rising incidence of diabetes and anaphylaxis, and patients preference to choose self-administration of injections.

Which usage type held the maximum share in 2022?

The disposable autoinjectors usage type held the maximum share of the autoinjectors industry.

Select Licence Type

Single User

US$ 3200

Multi User

US$ 5500

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date